Etomidate Injection Shortage: Latest Updates on Manufacturer Availability
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
The FDA reports a current shortage of Etomidate Injection, an anesthetic medication, though several manufacturers currently report that supply is available.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on February 11, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — Drug Shortages — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA drug-shortage notice is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (drug-shortage, fda, medication, Etomidate) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What's in Shortage
Etomidate Injection (Brand Name: ETOMIDATE) is currently listed in the FDA drug shortage database. This medication is primarily used within the therapeutic category of Anesthesia. The shortage was first posted on October 5, 2022, and was most recently updated on February 5, 2026.
Which Manufacturers Are Affected
While the drug remains on the shortage list, several manufacturers currently report that their presentations are available. Patients and providers should note the following status by company:
Mylan Institutional, a Viatris Company
- Status: Available
- Presentations: 2 mg/1 mL (NDC 67457-902-10) and 2 mg/1 mL (NDC 67457-903-20)
- Contact: 800-796-9526
Caplin Steriles, Ltd. (Marketed by Fresenius Kabi)
- Status: Available
- Presentations: 2 mg/mL (NDC 65219-447-20), 40 mg/20 mL (NDC 65219-445-20), and 2 mg/1 mL (NDC 65219-445-10)
- Notes: Check wholesalers for inventory.
- Contact: 800-551-7176
Caplin Steriles, Ltd. (Marketed by Armas Pharmaceuticals, Inc.)
- Status: Available
- Presentations: 2 mg/mL (NDC 72485-508-10) and 2 mg/mL (NDC 72485-509-10)
- Notes: Check wholesalers for inventory.
- Contact: 908-803-2586
Why There's a Shortage
No specific reason for the shortage of Etomidate Injection was provided in the current source data.
What Patients Should Do
If you are a patient scheduled for a procedure involving anesthesia, please be aware of the following steps:
- Consult Your Healthcare Provider: Always discuss your treatment plan and any concerns regarding medication availability with your doctor or surgical team.
- Speak with a Pharmacist: Hospital pharmacists are often the first to know about local inventory levels and can provide updates on supply.
- Contact Manufacturers: If necessary, the contact numbers provided above can be used to inquire about the most recent supply status.
Disclaimer: This article is for informational purposes only. Patients should consult their healthcare provider for medical advice and treatment options.
Source
Information provided by the FDA Drug Shortage Database.
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.
What is this FDA drug-shortage notice about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more Drug Shortages updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category